0001562180-15-000300.txt : 20150420 0001562180-15-000300.hdr.sgml : 20150420 20150420170851 ACCESSION NUMBER: 0001562180-15-000300 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150416 FILED AS OF DATE: 20150420 DATE AS OF CHANGE: 20150420 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 Broadway STREET 2: 14TH FLOOR CITY: Cambridge STATE: MA ZIP: 02142 BUSINESS PHONE: 617-225-4348 MAIL ADDRESS: STREET 1: 1 Broadway STREET 2: 14TH FLOOR CITY: Cambridge STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalowski Lee CENTRAL INDEX KEY: 0001618273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 15781217 MAIL ADDRESS: STREET 1: C/O TOKAI PHARMACEUTICALS, INC. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2015-04-16 false 0001404281 Tokai Pharmaceuticals Inc TKAI 0001618273 Kalowski Lee C/O TOKAI PHARMACEUTICALS, INC. 255 STATE STREET 6TH FLOOR BOSTON MA 02109 false true false false Chief Financial Officer Common Stock 2015-04-16 4 S false 4567.00 13.00 D 47779.00 D The sale reported on this Form 4 was effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. /s/ Cindy Driscoll, Attorney-in-Fact 2015-04-20